Editing Chlamydia (section)

====Women====
Chlamydial infection of the [[cervix]] (neck of the womb) is a sexually transmitted infection which has [[asymptomatic|no symptoms]] for  around 70% of women infected. The infection can be passed through vaginal, anal, oral, or manual sex. Of those who have an asymptomatic infection that is not detected by their doctor, approximately half will develop [[pelvic inflammatory disease]] (PID), a generic term for infection of the [[uterus]], [[fallopian tubes]], and/or [[ovaries]]. PID can cause scarring inside the [[reproductive organ]]s, which can later cause serious complications, including chronic [[pelvis|pelvic]] pain, difficulty becoming pregnant, [[ectopic pregnancy|ectopic (tubal) pregnancy]], and other dangerous complications of pregnancy.<ref name="pmid28835360"/>

Chlamydia is known as the "silent epidemic", as at least 70% of genital ''C. trachomatis'' infections in women (and 50% in men) are asymptomatic at the time of diagnosis,<ref name="NHS Chlamydia page">[http://www.nhs.uk/conditions/Chlamydia/Pages/Introduction.aspx NHS Chlamydia page] {{webarchive|url=https://web.archive.org/web/20130116082623/http://www.nhs.uk/conditions/Chlamydia/Pages/Introduction.aspx |date=2013-01-16 }}</ref> and can linger for months or years before being discovered. Signs and symptoms may include abnormal [[vaginal bleeding]] or discharge, abdominal pain, [[Dyspareunia|painful sexual intercourse]], [[fever]], [[Dysuria|painful urination]] or the urge to urinate more often than usual ([[urinary urgency]]).<ref name="pmid28835360">{{cite journal | vauthors = Witkin SS, Minis E, Athanasiou A, Leizer J, Linhares IM | title = Chlamydia trachomatis: the Persistent Pathogen | journal = Clinical and Vaccine Immunology | volume = 24 | issue = 10 | date = October 2017 | pmid = 28835360 | pmc = 5629669 | doi = 10.1128/CVI.00203-17 }}</ref>

For sexually active women who are not pregnant, screening is recommended in those under 25 and others at risk of infection.<ref name="AmFamPhys">{{cite journal | vauthors = Meyers D, Wolff T, Gregory K, Marion L, Moyer V, Nelson H, Petitti D, Sawaya GF | title = USPSTF recommendations for STI screening | journal = American Family Physician | volume = 77 | issue = 6 | pages = 819–824 | date = March 2008 | pmid = 18386598 | url = http://www.aafp.org/afp/20080315/819.html | access-date = 2008-03-17 | url-status = dead | archive-url = https://web.archive.org/web/20210828031335/https://www.aafp.org/afp/2008/0315/p819.html | archive-date = 2021-08-28 }}</ref> Risk factors include a history of chlamydial or other sexually transmitted infection, new or multiple sexual partners, and inconsistent [[condom]] use.<ref name="USPSTF">{{cite journal | vauthors = ((U.S. Preventive Services Task Force)) | title = Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement | journal = Annals of Internal Medicine | volume = 147 | issue = 2 | pages = 128–134 | date = July 2007 | pmid = 17576996 | doi = 10.7326/0003-4819-147-2-200707170-00172 | s2cid = 35816540 | url = http://www.ahrq.gov/clinic/uspstf07/chlamydia/chlamydiars.htm | url-status = live | doi-access =  | archive-url = https://web.archive.org/web/20080303022755/http://www.ahrq.gov/clinic/uspstf07/chlamydia/chlamydiars.htm | archive-date = 2008-03-03 }}</ref> Guidelines recommend all women attending for [[emergency contraception|emergency contraceptive]] are offered chlamydia testing, with studies showing up to 9% of women aged under 25 years had chlamydia.<ref>{{cite journal | vauthors = Yeung EY, Comben E, McGarry C, Warrington R | title = STI testing in emergency contraceptive consultations | journal = The British Journal of General Practice | volume = 65 | issue = 631 | pages = 63.1–64 | date = February 2015 | pmid = 25624285 | pmc = 4325454 | doi = 10.3399/bjgp15X683449 }}</ref>